Loading…

Oral Administration in Combination with Zinc Enhances β-Cryptoxanthin-Induced Anabolic Effects on Bone Components in the Femoral Tissues of Rats in Vivo

The effects of combined β-cryptoxanthin and zinc on bone components in the femoral-diaphyseal (cortical bone) and -metaphyseal (trabecular bone) tissues of rats in vivo were investigated. Rats were orally administered either vehicle, β-cryptoxanthin (5 or 10 μg/100 g body weight), zinc sulfate (0.1...

Full description

Saved in:
Bibliographic Details
Published in:Biological & pharmaceutical bulletin 2006, Vol.29(2), pp.371-374
Main Authors: Yamaguchi, Masayoshi, Uchiyama, Satoshi, Ishiyama, Kaori, Hashimoto, Ken
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The effects of combined β-cryptoxanthin and zinc on bone components in the femoral-diaphyseal (cortical bone) and -metaphyseal (trabecular bone) tissues of rats in vivo were investigated. Rats were orally administered either vehicle, β-cryptoxanthin (5 or 10 μg/100 g body weight), zinc sulfate (0.1 or 0.5 mg Zn/100 g), or their combination once a day for 7 d. Calcium content, alkaline phosphatase activity, and DNA content in the femoral-diaphyseal tissues was not significantly altered by the administration of β-cryptoxanthin (5 μg/100 g) or zinc (0.1 or 0.5 mg/100 g). Combined administration of β-cryptoxanthin (5 μg/100 g) and zinc (0.1 or 0.5 mg/100 g) caused a synergistic increase in calcium content, alkaline phosphatase activity, and DNA content in the diaphyseal tissues. The effect of β-cryptoxanthin (5 or 10 μg/100 g) in increasing calcium and DNA contents in the metaphyseal tissues was significantly enhanced by the combined administration of zinc (0.1 or 0.5 mg/100 g), but did not have a significant effect on the metaphyseal components. The metaphyseal alkaline phosphatase activity was markedly increased by the combination of β-cryptoxanthin (5 μg/100 g) and zinc (0.1 or 0.5 mg/100 g). This study demonstrates that the oral administration of the combination of zinc at lower doses synergistically enhances β-cryptoxanthin-induced anabolic effects on bone components in the femoral tissues of rats in vivo.
ISSN:0918-6158
1347-5215
DOI:10.1248/bpb.29.371